BioRender Icon

Child 4 (gender-neutral, stage I obesity, anterior)

Child 4 (gender-neutral, stage I obesity, anterior) - Editable icon of a gender-neutral child with stage I obesity with stage I obesity in an anterior anatomical position with South Asian facial features
[{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fc/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fc/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fd/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fd/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08fe/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08fe/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f08ff/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f08ff/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0900/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0900/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0901/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0901/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0902/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0902/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0903/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0903/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0904/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0904/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0905/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0905/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0906/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0906/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0907/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0907/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0908/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0908/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0909/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0909/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090a/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090a/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090b/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090b/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090c/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090c/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090d/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090d/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090e/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090e/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f090f/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f090f/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0910/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0910/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0911/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0911/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0912/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0912/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0913/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0913/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0914/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0914/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0915/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0915/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0916/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0916/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0917/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0917/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0918/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0918/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f0919/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f0919/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091a/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091a/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091b/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091b/671a99891adafe9ee12f08bc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99a11adafe9ee12f091c/671a99891adafe9ee12f08bc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99a11adafe9ee12f091c/671a99891adafe9ee12f08bc.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators
page dashboard

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
child,gender-neutral child,child gender neutral,gender-neutral,neutral,asexual,unsexed,sexless,male child,female child,boy child,girl child,boy,girl,young,young age,small child,children,kid,human child,minor,adolescent,preadolescence,preteen,preteenager,tween,tweenager,tweener,overweight,obese,obesity stage I,high BMI,excess weight,large,chubby,plus-sized,heavy,full-figured,above average weight,back,head,limbs,arm,leg,hand,foot,feet,anterior,frontal,front view,anterior view,front,nude,naked,without clothes,unclothed,human,human figure,figure,child development,development,puberty,pediatric,pediatrics,whole body,body,age,person,human anatomy,anatomy,South Asian,brown-skinned,dark skinned,dark complexion,brown,Indian,Pakistani,Bangladeshi,Desi,Indo,South Asian Diaspora,Sri Lankan,Nepalese,Bhutanese,Tamil,24q2-content-refinement,24q2-content-refinement-human-figure-diversity,child
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Child 4 (gender-neutral, stage I obesity, anterior) icon JPEG

Child 4 (gender-neutral, stage I obesity, anterior) icon PNG

Child 4 (gender-neutral, stage I obesity, anterior) icon SVG

Child 4 (gender-neutral, stage I obesity, anterior) icon GIF

Biorender Icon FAQs

How are scientists using the Child 4 (gender-neutral, stage I obesity, anterior) icon in their work?

BioRender users often use the Child 4 (gender-neutral, stage I obesity, anterior) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Child 4 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Child 4 (gender-neutral, stage I obesity, anterior) icon customizable in BioRender?

Most icons in BioRender, including the Child 4 (gender-neutral, stage I obesity, anterior) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Child 4 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes, figures containing the Child 4 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Child 4 (gender-neutral, stage I obesity, anterior) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Child 4 (gender-neutral, stage I obesity, anterior) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Child 4 (gender-neutral, stage I obesity, anterior) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon